{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:43:17Z","timestamp":1790858597680,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"The Crohn\u2019s and Colitis Foundation"},{"name":"International Organization for the Study of Inflammatory Bowel Disease"},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK129762-02"],"award-info":[{"award-number":["K23DK129762-02"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health\u2019s National Institute of Diabetes and Digestive and Kidney Diseases"},{"name":"Clinical and Translational Science Awards","award":["UL1TR004419"],"award-info":[{"award-number":["UL1TR004419"]}]},{"name":"Office of Research Infrastructure of the National Institutes of Health","award":["S10OD026880"],"award-info":[{"award-number":["S10OD026880"]}]},{"name":"Office of Research Infrastructure of the National Institutes of Health","award":["S10OD030463"],"award-info":[{"award-number":["S10OD030463"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10620-025-08864-9","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T19:27:06Z","timestamp":1737746826000},"page":"1150-1159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Elevated Fecal Lipocalin-2 Levels During Early Life Are Associated with Maternal Inflammatory Bowel Disease Diagnosis"],"prefix":"10.1007","volume":"70","author":[{"given":"Leonid","family":"Tarassishin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taegyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Barre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Rendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellissa","family":"Picker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Thj\u00f8m\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"M\u00f8rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Frederic","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"8864_CR1","first-page":"53","volume":"13","author":"I Bjarnason","year":"2017","unstructured":"Bjarnason I. The use of fecal calprotectin in inflammatory Bowel disease. Gastroenterol Hepatol. 2017;13:53\u201356.","journal-title":"Gastroenterol Hepatol."},{"key":"8864_CR2","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/MIB.0000000000001136","volume":"23","author":"M Julsgaard","year":"2017","unstructured":"Julsgaard M, Hvas CL, Gearry RB et al. Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017;23:1240\u20131246.","journal-title":"Inflamm Bowel Dis."},{"key":"8864_CR3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2020.11.050","volume":"160","author":"ES Kim","year":"2021","unstructured":"Kim ES, Tarassishin L, Eisele C et al. Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies. Gastroenterology. 2021;160:1118\u20131130.","journal-title":"Gastroenterology."},{"key":"8864_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejim.2020.03.015","volume":"77","author":"A Rottenstreich","year":"2020","unstructured":"Rottenstreich A, Mishael T, Granovsky SG et al. Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases. Eur J Intern Meds. 2020;77:105\u2013110.","journal-title":"Eur J Intern Meds."},{"key":"8864_CR5","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/ecco-jcc\/jjad096","volume":"17","author":"J Sabino","year":"2023","unstructured":"Sabino J, Tarassishin L, Eisele C et al. Influence of Early Life Factors, including Breastmilk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease. J Crohns Colitis. 2023;17:1723\u20131732.","journal-title":"J Crohns Colitis."},{"key":"8864_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/gutjnl-2018-317855","volume":"69","author":"J Torres","year":"2020","unstructured":"Torres J, Hu J, Seki A et al. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice. Gut. 2020;69:42\u201351.","journal-title":"Gut."},{"key":"8864_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/gutjnl-2019-318263","volume":"69","author":"J van der Giessen","year":"2020","unstructured":"van der Giessen J, Binyamin D, Belogolovski A et al. Modulation of cytokine patterns and microbiome during pregnancy in IBD. Gut. 2020;69:473\u2013486.","journal-title":"Gut."},{"key":"8864_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VT Aho","year":"2021","unstructured":"Aho VT, Houser MC, Pereira PA et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol Neurodegener. 2021;16:1\u201314.","journal-title":"Mol Neurodegener."},{"key":"8864_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ibd\/izx011","volume":"24","author":"M Di Ruscio","year":"2017","unstructured":"Di Ruscio M, Vernia F, Ciccone A, Frieri G, Latella G. Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? Inflamm Bowel Dis. 2017;24:78\u201392.","journal-title":"Inflamm Bowel Dis."},{"key":"8864_CR10","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","volume":"268","author":"L Kjeldsen","year":"1993","unstructured":"Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425\u201310432.","journal-title":"J Biol Chem."},{"key":"8864_CR11","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1515\/cclm-2012-0227","volume":"50","author":"K Makris","year":"2012","unstructured":"Makris K, Rizos D, Kafkas N, Haliassos A. Neurophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine. Clin Chem Lab Med. 2012;50:1519\u20131532.","journal-title":"Clin Chem Lab Med."},{"key":"8864_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00441-018-2860-8","volume":"374","author":"S Thorsvik","year":"2018","unstructured":"Thorsvik S, Bakke I, van Beelen Granlund A et al. Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn\u2019s disease. Cell Tissue Res. 2018;374:339\u2013348.","journal-title":"Cell Tissue Res."},{"key":"8864_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/ecco-jcc\/jjaa124","volume":"15","author":"A Zollner","year":"2021","unstructured":"Zollner A, Schmiderer A, Reider SJ et al. Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study. J Crohns Colitis. 2021;15:43\u201354.","journal-title":"J Crohns Colitis."},{"key":"8864_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jgh.13598","volume":"32","author":"S Thorsvik","year":"2017","unstructured":"Thorsvik S, Dam\u00e5s JK, Granlund AV et al. Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease. J Gastroenterol Hepatol. 2017;32:128\u2013135.","journal-title":"J Gastroenterol Hepatol."},{"key":"8864_CR15","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1097\/MCG.0000000000000837","volume":"52","author":"A Buisson","year":"2018","unstructured":"Buisson A, Vazeille E, Minet-Quinard R et al. Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases. J Clin Gastroenterol. 2018;52:e53\u2013e62.","journal-title":"J Clin Gastroenterol."},{"key":"8864_CR16","doi-asserted-by":"crossref","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting Linear Mixed-Effects Models Using lme4. arXiv preprint. 2014; arXiv:1406.5823.","DOI":"10.18637\/jss.v067.i01"},{"key":"8864_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fped.2017.00111","volume":"5","author":"N Amenyogbe","year":"2017","unstructured":"Amenyogbe N, Kollmann TR, Ben-Othman R. Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development. Front Pediatr. 2017;5:111.","journal-title":"Front Pediatr."},{"key":"8864_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","volume":"28","author":"AR Moschen","year":"2017","unstructured":"Moschen AR, Adolph TE, Gerner RR, Wieser V, Tilg H. Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation. Trends Endocrinol Metab. 2017;28:388\u2013397.","journal-title":"Trends Endocrinol Metab."},{"key":"8864_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/j.1536-4801.2002.tb07615.x","volume":"34","author":"J Rugtveit","year":"2002","unstructured":"Rugtveit J, Fagerhol MK. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr. 2002;34:323\u2013324.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"8864_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12026-022-09352-2","volume":"71","author":"S Asaf","year":"2023","unstructured":"Asaf S, Maqsood F, Jalil J et al. Lipocalin 2\u2014not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials. Immunol Res. 2023;71:287\u2013313.","journal-title":"Immunol Res."},{"key":"8864_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12967-021-02839-w","volume":"19","author":"M Kaczmarczyk","year":"2021","unstructured":"Kaczmarczyk M, L\u00f6ber U, Adamek K et al. The gut microbiota is associated with the small intestinal paracellular permeability and the development of the immune system in healthy children during the first two years of life. J Transl Med. 2021;19:177.","journal-title":"J Transl Med."},{"key":"8864_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J, Arze C, Ananthakrishnan AN et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569:655\u2013662.","journal-title":"Nature."},{"key":"8864_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","volume":"66","author":"V Pascal","year":"2017","unstructured":"Pascal V, Pozuelo M, Borruel N et al. A microbial signature for Crohn\u2019s disease. Gut. 2017;66:813\u2013822.","journal-title":"Gut."},{"key":"8864_CR24","doi-asserted-by":"crossref","unstructured":"Sheh A, Artim SC, Burns MA, et al. Common Marmoset Gut Microbiome Profiles in Health and Intestinal Disease. bioRxiv. 2020; 2020.2008.2027.268524.","DOI":"10.1101\/2020.08.27.268524"},{"key":"8864_CR25","doi-asserted-by":"publisher","first-page":"6654","DOI":"10.1038\/s41598-022-10548-7","volume":"12","author":"R Ventin-Holmberg","year":"2022","unstructured":"Ventin-Holmberg R, H\u00f6yhty\u00e4 M, Saqib S et al. The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-\u03b1. Scientific Reports. 2022;12:6654.","journal-title":"Scientific Reports."},{"key":"8864_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/jcm5120118","volume":"5","author":"O W\u00e9ra","year":"2016","unstructured":"W\u00e9ra O, Lancellotti P, Oury C. The Dual Role of Neutrophils in Inflammatory Bowel Diseases. J Clin Med. 2016;5:118.","journal-title":"J Clin Med."},{"key":"8864_CR27","doi-asserted-by":"publisher","first-page":"S413","DOI":"10.1016\/S0016-5085(19)37883-7","volume":"156","author":"S-H Lee","year":"2019","unstructured":"Lee S-H, Power N, Turpin W, Bedrani L. Sa1816: elevated Fecal calprotectin in healthy first degree relatives of patients with Crohn\u2019s Disease is associated with future diagnosis of Crohn\u2019s disease. Gastroenterology 2019;156:S-413.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08864-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-08864-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08864-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:22:26Z","timestamp":1742314946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-08864-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["8864"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-08864-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest relevant to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is an observational study. This study was approved by the Institutional Review Board of the Icahn School of Medicine at Mount Sinai (HS#14-00554).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}